Invention Grant
- Patent Title: Anti-mesothelin antibody and composition comprising the same
-
Application No.: US15762885Application Date: 2016-09-23
-
Publication No.: US10851175B2Publication Date: 2020-12-01
- Inventor: Dong-Sik Kim , Eun Jung Song , Mijung Lee , Eun-Hee Lee , Miyoung Oh , Jae Chan Park , Kisu Kim , Sujeong Kim , Hyung-Kwon Lim , Kyuhyun Lee , Jongwha Won , Soongyu Choi , Young Seoub Park
- Applicant: MOGAM INSTITUTE FOR BIOMEDICAL RESEARCH , GREEN CROSS CORPORATION
- Applicant Address: KR Gyeonggi-do KR Gyeonggi-do
- Assignee: MOGAM INSTITUTE FOR BIOMEDICAL RESEARCH,GREEN CROSS CORPORATION
- Current Assignee: MOGAM INSTITUTE FOR BIOMEDICAL RESEARCH,GREEN CROSS CORPORATION
- Current Assignee Address: KR Gyeonggi-do KR Gyeonggi-do
- Agency: Cantor Colburn LLP
- Priority: KR10-2015-0135755 20150924
- International Application: PCT/KR2016/010604 WO 20160923
- International Announcement: WO2017/052241 WO 20170330
- Main IPC: C07K16/18
- IPC: C07K16/18 ; C07K16/30 ; C07K16/28
Abstract:
The present invention relates to an antibody specifically bound to mesothelin (MSLN), a nucleic acid encoding the antibody, a vector and a host cell including the nucleic acid, a method for producing the antibody, and a pharmaceutical composition for treating cancer or tumor including the antibody as an active ingredient. The antibody specifically bound to the mesothelin according to the present invention has high affinity and specificity to an antigen, such that it is possible to develop an antibody effectively usable for treatment or diagnosis of cancer or tumor diseases.
Public/Granted literature
- US20180346588A1 NOVEL ANTI-MESOTHELIN ANTIBODY AND COMPOSITION COMPRISING THE SAME Public/Granted day:2018-12-06
Information query
